nodes	percent_of_prediction	percent_of_DWPC	metapath
Dacarbazine—muscle cancer—uterine cancer	0.409	0.556	CtDrD
Dacarbazine—sarcoma—uterine cancer	0.326	0.444	CtDrD
Dacarbazine—CYP1A1—Progesterone—uterine cancer	0.079	0.502	CbGbCtD
Dacarbazine—CYP1A2—Progesterone—uterine cancer	0.0353	0.224	CbGbCtD
Dacarbazine—CYP2E1—Etoposide—uterine cancer	0.0273	0.173	CbGbCtD
Dacarbazine—CYP1A2—Etoposide—uterine cancer	0.0158	0.1	CbGbCtD
Dacarbazine—POLA2—Removal of the Flap Intermediate—POLD1—uterine cancer	0.00531	0.0765	CbGpPWpGaD
Dacarbazine—POLA2—Leading Strand Synthesis—POLD1—uterine cancer	0.00531	0.0765	CbGpPWpGaD
Dacarbazine—POLA2—Processive synthesis on the lagging strand—POLD1—uterine cancer	0.00478	0.0688	CbGpPWpGaD
Dacarbazine—POLA2—uterine cervix—uterine cancer	0.00413	0.11	CbGeAlD
Dacarbazine—POLA2—Lagging Strand Synthesis—POLD1—uterine cancer	0.00384	0.0553	CbGpPWpGaD
Dacarbazine—POLA2—Telomere C-strand (Lagging Strand) Synthesis—POLD1—uterine cancer	0.00357	0.0514	CbGpPWpGaD
Dacarbazine—POLA2—uterus—uterine cancer	0.00345	0.0917	CbGeAlD
Dacarbazine—POLA2—female reproductive system—uterine cancer	0.0031	0.0825	CbGeAlD
Dacarbazine—POLA2—Extension of Telomeres—POLD1—uterine cancer	0.00297	0.0427	CbGpPWpGaD
Dacarbazine—POLA2—female gonad—uterine cancer	0.00282	0.075	CbGeAlD
Dacarbazine—POLA2—vagina—uterine cancer	0.0028	0.0746	CbGeAlD
Dacarbazine—POLA2—DNA strand elongation—POLD1—uterine cancer	0.00274	0.0395	CbGpPWpGaD
Dacarbazine—POLA2—G1 to S cell cycle control—CDKN1C—uterine cancer	0.00265	0.0381	CbGpPWpGaD
Dacarbazine—POLA2—E2F mediated regulation of DNA replication—RRM2—uterine cancer	0.00223	0.0321	CbGpPWpGaD
Dacarbazine—POLA2—DNA Replication—POLD1—uterine cancer	0.00221	0.0318	CbGpPWpGaD
Dacarbazine—POLA2—lymph node—uterine cancer	0.00181	0.0482	CbGeAlD
Dacarbazine—PGD—myometrium—uterine cancer	0.00168	0.0446	CbGeAlD
Dacarbazine—POLA2—Telomere Maintenance—POLD1—uterine cancer	0.00134	0.0194	CbGpPWpGaD
Dacarbazine—PGD—uterine cervix—uterine cancer	0.0013	0.0347	CbGeAlD
Dacarbazine—PGD—smooth muscle tissue—uterine cancer	0.00127	0.0337	CbGeAlD
Dacarbazine—PGD—decidua—uterine cancer	0.00124	0.0331	CbGeAlD
Dacarbazine—PGD—renal system—uterine cancer	0.00122	0.0325	CbGeAlD
Dacarbazine—CYP1A1—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.0012	0.0173	CbGpPWpGaD
Dacarbazine—PGD—endometrium—uterine cancer	0.00118	0.0314	CbGeAlD
Dacarbazine—PGD—mammalian vulva—uterine cancer	0.00114	0.0304	CbGeAlD
Dacarbazine—POLA2—Synthesis of DNA—POLD1—uterine cancer	0.00114	0.0164	CbGpPWpGaD
Dacarbazine—POLA2—Chromosome Maintenance—POLD1—uterine cancer	0.00112	0.0161	CbGpPWpGaD
Dacarbazine—PGD—uterus—uterine cancer	0.00109	0.0289	CbGeAlD
Dacarbazine—POLA2—DNA Replication—POLD1—uterine cancer	0.00107	0.0154	CbGpPWpGaD
Dacarbazine—PGD—female reproductive system—uterine cancer	0.000977	0.026	CbGeAlD
Dacarbazine—POLA2—S Phase—POLD1—uterine cancer	0.000934	0.0134	CbGpPWpGaD
Dacarbazine—CYP1A1—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000926	0.0133	CbGpPWpGaD
Dacarbazine—PGD—female gonad—uterine cancer	0.000889	0.0237	CbGeAlD
Dacarbazine—PGD—vagina—uterine cancer	0.000883	0.0235	CbGeAlD
Dacarbazine—POLA2—G1/S Transition—RRM2—uterine cancer	0.000858	0.0123	CbGpPWpGaD
Dacarbazine—POLA2—G1 to S cell cycle control—CDKN2B—uterine cancer	0.000755	0.0109	CbGpPWpGaD
Dacarbazine—POLA2—Mitotic G1-G1/S phases—RRM2—uterine cancer	0.000723	0.0104	CbGpPWpGaD
Dacarbazine—CYP1A1—epithelium—uterine cancer	0.000627	0.0167	CbGeAlD
Dacarbazine—CYP1A1—uterine cervix—uterine cancer	0.000621	0.0165	CbGeAlD
Dacarbazine—PGD—NRF2 pathway—NFE2L2—uterine cancer	0.000603	0.00868	CbGpPWpGaD
Dacarbazine—CYP1A2—renal system—uterine cancer	0.000589	0.0157	CbGeAlD
Dacarbazine—CYP1A1—renal system—uterine cancer	0.000581	0.0155	CbGeAlD
Dacarbazine—PGD—NRF2 pathway—GPX3—uterine cancer	0.000575	0.00828	CbGpPWpGaD
Dacarbazine—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—uterine cancer	0.000575	0.00828	CbGpPWpGaD
Dacarbazine—PGD—lymph node—uterine cancer	0.000571	0.0152	CbGeAlD
Dacarbazine—CYP1A1—mammalian vulva—uterine cancer	0.000544	0.0145	CbGeAlD
Dacarbazine—CYP2E1—renal system—uterine cancer	0.00053	0.0141	CbGeAlD
Dacarbazine—CYP1A1—uterus—uterine cancer	0.000518	0.0138	CbGeAlD
Dacarbazine—POLA2—Mitotic M-M/G1 phases—NDC80—uterine cancer	0.0005	0.0072	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—MLH3—uterine cancer	0.000478	0.00688	CbGpPWpGaD
Dacarbazine—CYP1A1—female reproductive system—uterine cancer	0.000466	0.0124	CbGeAlD
Dacarbazine—POLA2—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	0.000436	0.00628	CbGpPWpGaD
Dacarbazine—POLA2—G1 to S cell cycle control—CDKN2A—uterine cancer	0.000432	0.00621	CbGpPWpGaD
Dacarbazine—CYP2E1—female reproductive system—uterine cancer	0.000425	0.0113	CbGeAlD
Dacarbazine—CYP1A1—female gonad—uterine cancer	0.000424	0.0113	CbGeAlD
Dacarbazine—CYP1A1—Oxidative Stress—NFE2L2—uterine cancer	0.000423	0.00608	CbGpPWpGaD
Dacarbazine—CYP1A1—vagina—uterine cancer	0.000421	0.0112	CbGeAlD
Dacarbazine—CYP1A1—Oxidative Stress—GPX3—uterine cancer	0.000403	0.0058	CbGpPWpGaD
Dacarbazine—POLA2—G1 to S cell cycle control—CDKN1B—uterine cancer	0.000382	0.0055	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000374	0.00538	CbGpPWpGaD
Dacarbazine—CYP1A1—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000359	0.00517	CbGpPWpGaD
Dacarbazine—PGD—Carbohydrate metabolism—DCN—uterine cancer	0.000358	0.00516	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—NDC80—uterine cancer	0.000334	0.00481	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000318	0.00458	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.0003	0.00432	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.0003	0.00432	CbGpPWpGaD
Dacarbazine—POLA2—Synthesis of DNA—CDKN1B—uterine cancer	0.00029	0.00418	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—POLD1—uterine cancer	0.000284	0.00409	CbGpPWpGaD
Dacarbazine—CYP1A1—lymph node—uterine cancer	0.000272	0.00725	CbGeAlD
Dacarbazine—POLA2—DNA Replication—CDKN1B—uterine cancer	0.000272	0.00392	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000265	0.00382	CbGpPWpGaD
Dacarbazine—POLA2—G1/S Transition—CDKN1B—uterine cancer	0.000262	0.00377	CbGpPWpGaD
Dacarbazine—POLA2—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.000249	0.00359	CbGpPWpGaD
Dacarbazine—POLA2—G1 to S cell cycle control—TP53—uterine cancer	0.00024	0.00346	CbGpPWpGaD
Dacarbazine—POLA2—S Phase—CDKN1B—uterine cancer	0.000238	0.00343	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—RRM2—uterine cancer	0.000237	0.00341	CbGpPWpGaD
Dacarbazine—CYP1A1—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000235	0.00338	CbGpPWpGaD
Dacarbazine—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000229	0.0033	CbGpPWpGaD
Dacarbazine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000228	0.00328	CbGpPWpGaD
Dacarbazine—CYP2E1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000225	0.00324	CbGpPWpGaD
Dacarbazine—POLA2—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000221	0.00318	CbGpPWpGaD
Dacarbazine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000215	0.00309	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000213	0.00306	CbGpPWpGaD
Dacarbazine—CYP1A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000212	0.00305	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—MLH1—uterine cancer	0.000211	0.00303	CbGpPWpGaD
Dacarbazine—CYP2E1—Tryptophan metabolism—CYP19A1—uterine cancer	0.000207	0.00299	CbGpPWpGaD
Dacarbazine—CYP1A1—Tryptophan metabolism—CYP19A1—uterine cancer	0.000196	0.00282	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.000191	0.00276	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.000191	0.00276	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—YWHAE—uterine cancer	0.00019	0.00274	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—NDUFB11—uterine cancer	0.000185	0.00267	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—SRD5A2—uterine cancer	0.000185	0.00267	CbGpPWpGaD
Dacarbazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000185	0.00266	CbGpPWpGaD
Dacarbazine—POLA2—Mitotic M-M/G1 phases—BIRC5—uterine cancer	0.000185	0.00266	CbGpPWpGaD
Dacarbazine—CYP1A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000174	0.00251	CbGpPWpGaD
Dacarbazine—CYP2E1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000174	0.00251	CbGpPWpGaD
Dacarbazine—PGD—Disease—AKR1B10—uterine cancer	0.000172	0.00248	CbGpPWpGaD
Dacarbazine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000168	0.00241	CbGpPWpGaD
Dacarbazine—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000166	0.00238	CbGpPWpGaD
Dacarbazine—CYP1A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000164	0.00236	CbGpPWpGaD
Dacarbazine—CYP2E1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000162	0.00233	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.00016	0.0023	CbGpPWpGaD
Dacarbazine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000158	0.00228	CbGpPWpGaD
Dacarbazine—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000156	0.00225	CbGpPWpGaD
Dacarbazine—CYP1A1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000153	0.0022	CbGpPWpGaD
Dacarbazine—CYP1A2—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.00015	0.00216	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—CDKN2B—uterine cancer	0.000143	0.00206	CbGpPWpGaD
Dacarbazine—PGD—Disease—RNF43—uterine cancer	0.000142	0.00205	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000138	0.00199	CbGpPWpGaD
Dacarbazine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000137	0.00197	CbGpPWpGaD
Dacarbazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000136	0.00196	CbGpPWpGaD
Dacarbazine—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000135	0.00195	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—STAR—uterine cancer	0.000134	0.00193	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—AKR1B1—uterine cancer	0.000134	0.00193	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000131	0.00188	CbGpPWpGaD
Dacarbazine—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000128	0.00185	CbGpPWpGaD
Dacarbazine—CYP1A2—Tryptophan metabolism—CYP19A1—uterine cancer	0.000125	0.0018	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—BIRC5—uterine cancer	0.000123	0.00178	CbGpPWpGaD
Dacarbazine—CYP2E1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000119	0.00171	CbGpPWpGaD
Dacarbazine—PGD—Disease—AKR1C1—uterine cancer	0.000117	0.00169	CbGpPWpGaD
Dacarbazine—CYP1A1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000112	0.00161	CbGpPWpGaD
Dacarbazine—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000111	0.0016	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—POLD1—uterine cancer	0.000105	0.00151	CbGpPWpGaD
Dacarbazine—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	0.000105	0.00151	CbGpPWpGaD
Dacarbazine—CYP2E1—Metapathway biotransformation—GPX3—uterine cancer	0.000104	0.0015	CbGpPWpGaD
Dacarbazine—PGD—Disease—DCN—uterine cancer	0.000102	0.00146	CbGpPWpGaD
Dacarbazine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000101	0.00145	CbGpPWpGaD
Dacarbazine—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	9.95e-05	0.00143	CbGpPWpGaD
Dacarbazine—CYP1A1—Metapathway biotransformation—GPX3—uterine cancer	9.83e-05	0.00142	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—AKR1C1—uterine cancer	9.83e-05	0.00141	CbGpPWpGaD
Dacarbazine—CYP2E1—Biological oxidations—CYP11A1—uterine cancer	9.82e-05	0.00141	CbGpPWpGaD
Dacarbazine—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	9.73e-05	0.0014	CbGpPWpGaD
Dacarbazine—CYP2E1—Metapathway biotransformation—CYP11A1—uterine cancer	9.68e-05	0.00139	CbGpPWpGaD
Dacarbazine—CYP1A1—Biological oxidations—CYP11A1—uterine cancer	9.26e-05	0.00133	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—CDKN2A—uterine cancer	9.15e-05	0.00132	CbGpPWpGaD
Dacarbazine—CYP2E1—Metapathway biotransformation—AKR1C3—uterine cancer	9.15e-05	0.00132	CbGpPWpGaD
Dacarbazine—CYP1A1—Metapathway biotransformation—CYP11A1—uterine cancer	9.13e-05	0.00131	CbGpPWpGaD
Dacarbazine—PGD—Disease—AKR1C3—uterine cancer	9.03e-05	0.0013	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	8.88e-05	0.00128	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	8.88e-05	0.00128	CbGpPWpGaD
Dacarbazine—PGD—Disease—HMGA1—uterine cancer	8.8e-05	0.00127	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—RRM2—uterine cancer	8.76e-05	0.00126	CbGpPWpGaD
Dacarbazine—CYP1A1—Metapathway biotransformation—AKR1C3—uterine cancer	8.62e-05	0.00124	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—DCN—uterine cancer	8.5e-05	0.00122	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	8.33e-05	0.0012	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.22e-05	0.00118	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—CDKN2A—uterine cancer	8.18e-05	0.00118	CbGpPWpGaD
Dacarbazine—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	8.18e-05	0.00118	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—CDKN1B—uterine cancer	8.1e-05	0.00117	CbGpPWpGaD
Dacarbazine—PGD—Disease—FBXW7—uterine cancer	8.05e-05	0.00116	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—CYP11A1—uterine cancer	8.01e-05	0.00115	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	7.8e-05	0.00112	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	7.8e-05	0.00112	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—AKR1C3—uterine cancer	7.57e-05	0.00109	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	7.39e-05	0.00106	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	7.3e-05	0.00105	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—CDKN1B—uterine cancer	7.24e-05	0.00104	CbGpPWpGaD
Dacarbazine—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	7.22e-05	0.00104	CbGpPWpGaD
Dacarbazine—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	7.14e-05	0.00103	CbGpPWpGaD
Dacarbazine—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	7.12e-05	0.00103	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—EP300—uterine cancer	7.11e-05	0.00102	CbGpPWpGaD
Dacarbazine—CYP1A1—Biological oxidations—CYP19A1—uterine cancer	6.81e-05	0.00098	CbGpPWpGaD
Dacarbazine—CYP1A1—Metapathway biotransformation—CYP19A1—uterine cancer	6.72e-05	0.000967	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—EP300—uterine cancer	6.36e-05	0.000916	CbGpPWpGaD
Dacarbazine—PGD—Disease—CDKN2B—uterine cancer	6.31e-05	0.000908	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	6.28e-05	0.000904	CbGpPWpGaD
Dacarbazine—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	6.27e-05	0.000902	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.94e-05	0.000855	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.94e-05	0.000855	CbGpPWpGaD
Dacarbazine—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	5.9e-05	0.00085	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—STK11—uterine cancer	5.89e-05	0.000848	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—CYP19A1—uterine cancer	5.89e-05	0.000848	CbGpPWpGaD
Dacarbazine—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	5.82e-05	0.000838	CbGpPWpGaD
Dacarbazine—PGD—Disease—SMAD3—uterine cancer	5.76e-05	0.000829	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	5.66e-05	0.000815	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	5.66e-05	0.000815	CbGpPWpGaD
Dacarbazine—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	5.5e-05	0.000791	CbGpPWpGaD
Dacarbazine—PGD—Disease—FGFR2—uterine cancer	5.49e-05	0.000791	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	5.34e-05	0.000768	CbGpPWpGaD
Dacarbazine—PGD—Disease—MTHFR—uterine cancer	5.29e-05	0.000761	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.24e-05	0.000754	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	4.97e-05	0.000716	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	4.97e-05	0.000716	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	4.71e-05	0.000678	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	4.65e-05	0.00067	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—TP53—uterine cancer	4.55e-05	0.000655	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—MTHFR—uterine cancer	4.43e-05	0.000638	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.36e-05	0.000628	CbGpPWpGaD
Dacarbazine—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	4.34e-05	0.000625	CbGpPWpGaD
Dacarbazine—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	4.28e-05	0.000617	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	4e-05	0.000576	CbGpPWpGaD
Dacarbazine—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	3.88e-05	0.000559	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—SRD5A2—uterine cancer	3.88e-05	0.000559	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—NDUFB11—uterine cancer	3.88e-05	0.000559	CbGpPWpGaD
Dacarbazine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	3.8e-05	0.000547	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.79e-05	0.000545	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.79e-05	0.000545	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—NDUFB11—uterine cancer	3.66e-05	0.000527	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—SRD5A2—uterine cancer	3.66e-05	0.000527	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.55e-05	0.000512	CbGpPWpGaD
Dacarbazine—PGD—Disease—ERBB2—uterine cancer	3.45e-05	0.000497	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	3.4e-05	0.00049	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.36e-05	0.000483	CbGpPWpGaD
Dacarbazine—PGD—Disease—CDKN1B—uterine cancer	3.2e-05	0.00046	CbGpPWpGaD
Dacarbazine—PGD—Disease—CTNNB1—uterine cancer	3.02e-05	0.000435	CbGpPWpGaD
Dacarbazine—PGD—Disease—PTEN—uterine cancer	2.94e-05	0.000423	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—AKR1B1—uterine cancer	2.81e-05	0.000404	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—STAR—uterine cancer	2.81e-05	0.000404	CbGpPWpGaD
Dacarbazine—PGD—Disease—EP300—uterine cancer	2.81e-05	0.000404	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.78e-05	0.0004	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—STAR—uterine cancer	2.65e-05	0.000381	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—AKR1B1—uterine cancer	2.65e-05	0.000381	CbGpPWpGaD
Dacarbazine—PGD—Disease—NRAS—uterine cancer	2.62e-05	0.000378	CbGpPWpGaD
Dacarbazine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	2.62e-05	0.000377	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.62e-05	0.000376	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—PTEN—uterine cancer	2.46e-05	0.000355	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—EP300—uterine cancer	2.35e-05	0.000338	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—NDUFB11—uterine cancer	2.33e-05	0.000336	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—SRD5A2—uterine cancer	2.33e-05	0.000336	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.27e-05	0.000326	CbGpPWpGaD
Dacarbazine—PGD—Disease—KRAS—uterine cancer	2.26e-05	0.000325	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—POLD1—uterine cancer	2.2e-05	0.000317	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.14e-05	0.000308	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—POLD1—uterine cancer	2.08e-05	0.000299	CbGpPWpGaD
Dacarbazine—PGD—Disease—PIK3CA—uterine cancer	2.08e-05	0.000299	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—AKR1C1—uterine cancer	2.06e-05	0.000297	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—AKR1C1—uterine cancer	1.94e-05	0.00028	CbGpPWpGaD
Dacarbazine—PGD—Disease—HRAS—uterine cancer	1.92e-05	0.000276	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—RRM2—uterine cancer	1.84e-05	0.000264	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—DCN—uterine cancer	1.78e-05	0.000257	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—PIK3CA—uterine cancer	1.74e-05	0.00025	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—RRM2—uterine cancer	1.73e-05	0.000249	CbGpPWpGaD
Dacarbazine—PGD—Disease—AKT1—uterine cancer	1.7e-05	0.000244	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—STAR—uterine cancer	1.69e-05	0.000243	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.69e-05	0.000243	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—DCN—uterine cancer	1.68e-05	0.000242	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.68e-05	0.000242	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.67e-05	0.00024	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.59e-05	0.000228	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—CYP11A1—uterine cancer	1.58e-05	0.000228	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—AKR1C3—uterine cancer	1.5e-05	0.000215	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—AKT1—uterine cancer	1.42e-05	0.000204	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—POLD1—uterine cancer	1.32e-05	0.000191	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.24e-05	0.000178	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—STK11—uterine cancer	1.24e-05	0.000178	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—CYP19A1—uterine cancer	1.24e-05	0.000178	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.16e-05	0.000168	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—STK11—uterine cancer	1.16e-05	0.000168	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—RRM2—uterine cancer	1.1e-05	0.000159	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.09e-05	0.000157	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—DCN—uterine cancer	1.07e-05	0.000154	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.04e-05	0.00015	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.01e-05	0.000145	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—AKR1C3—uterine cancer	9.53e-06	0.000137	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—MTHFR—uterine cancer	9.28e-06	0.000134	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—MTHFR—uterine cancer	8.75e-06	0.000126	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.71e-06	0.000111	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—CYP19A1—uterine cancer	7.43e-06	0.000107	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—STK11—uterine cancer	7.43e-06	0.000107	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.97e-06	0.0001	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.65e-06	9.57e-05	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—MTHFR—uterine cancer	5.58e-06	8.03e-05	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—PTEN—uterine cancer	5.16e-06	7.43e-05	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—EP300—uterine cancer	4.93e-06	7.09e-05	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.92e-06	7.08e-05	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—PTEN—uterine cancer	4.87e-06	7.01e-05	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—EP300—uterine cancer	4.64e-06	6.68e-05	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—PIK3CA—uterine cancer	3.64e-06	5.24e-05	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—PIK3CA—uterine cancer	3.43e-06	4.94e-05	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—PTEN—uterine cancer	3.1e-06	4.47e-05	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—AKT1—uterine cancer	2.98e-06	4.28e-05	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—EP300—uterine cancer	2.96e-06	4.26e-05	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—AKT1—uterine cancer	2.81e-06	4.04e-05	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.19e-06	3.15e-05	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—AKT1—uterine cancer	1.79e-06	2.58e-05	CbGpPWpGaD
